Molemate Demonstration

Simsys Molemate After a 10 minute demonstration of the molemate™ system, the gps were given 90 minutes, including a refreshment break, to complete the training program. one gp was unable to complete the program due to a computer malfunction. Mole mate is a painless, non invasive and fast diagnostic tool for screening moles on your body.

Molemate Pen Grey Portland Clothing Wayne hicks, the sales and operations manager at schuco, recently gave a demonstration of the molemate to professionals from primary care. the molemate is specifically designed with and for general practitioners and skin specialists. The original siascopic diagnostic algorithm did not perform well in primary care settings because of the high prevalence of sks and hemangiomas seen in that patient population; therefore, a primary care scoring algorithm was developed that would eventually be called molemate. Demonstration introduction and illustration of features seen with the molematetm system, using siascans of 13 pigmented skin lesions. You will be presented with a number of lesions acquired with the molemate system that display the features to look out for. these features will be pointed out to you on the image.

Shop Hot Pink Press Demonstration introduction and illustration of features seen with the molematetm system, using siascans of 13 pigmented skin lesions. You will be presented with a number of lesions acquired with the molemate system that display the features to look out for. these features will be pointed out to you on the image. Can electronic clinical decision support (ecds) impact cancer outcomes using cancer registry data? how does ecds implementation effect gps, patients, the consultation? the molemate trial was funded by the national institute for health research school for primary care research (nihr spcr). Mole mate is a painless, non invasive and fast diagnostic tool for screening moles on your body. The systematic application of best practice guidelines alone was more accurate than the molemate system, and both performed better than reports of current practice. This trial tests the hypothesis that adding the molemate system to current best primary care practice will increase the proportion of appropriate referrals of suspicious pigmented lesions to secondary care compared with current best practice alone.